{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:03:43Z","timestamp":1790517823309,"version":"4.1.0"},"reference-count":211,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009727","name":"Hospital Research Foundation","doi-asserted-by":"publisher","award":["Mid-Career Fellowship"],"award-info":[{"award-number":["Mid-Career Fellowship"]}],"id":[{"id":"10.13039\/100009727","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s13346-021-00921-w","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T12:03:01Z","timestamp":1614945781000},"page":"1598-1624","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Nano-fats for bugs: the benefits of lipid nanoparticles for antimicrobial therapy"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3952-4501","authenticated-orcid":false,"given":"Chelsea R.","family":"Thorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8920-1391","authenticated-orcid":false,"given":"Nicky","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5434-590X","authenticated-orcid":false,"given":"Ben J.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5401-7535","authenticated-orcid":false,"given":"Clive A.","family":"Prestidge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,5]]},"reference":[{"key":"921_CR1","unstructured":"WHO. The top 10 causes of death. 2018."},{"issue":"2","key":"921_CR2","doi-asserted-by":"publisher","first-page":"e1700","DOI":"10.1371\/journal.pone.0001700","volume":"3","author":"DM Wolf","year":"2008","unstructured":"Wolf DM, et al. Memory in microbes: quantifying history-dependent behavior in a bacterium. PLoS One. 2008;3(2):e1700.","journal-title":"PLoS One"},{"issue":"2","key":"921_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1128\/CMR.00059-12","volume":"26","author":"A Beceiro","year":"2013","unstructured":"Beceiro A, Tom\u00e1s M, Bou G. Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world? Clin Microbiol Rev. 2013;26(2):185\u2013230.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"921_CR4","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/apm.12673","volume":"125","author":"O Ciofu","year":"2017","unstructured":"Ciofu O, et al. Antibiotic treatment of biofilm infections. APMIS. 2017;125(4):304\u201319.","journal-title":"APMIS"},{"key":"921_CR5","doi-asserted-by":"crossref","unstructured":"Thakur A, Mikkelsen H, Jungersen G.\u00a0Intracellular pathogens: host immunity and microbial persistence strategies. J Immunol Res. 2019.\u00a0","DOI":"10.1155\/2019\/1356540"},{"key":"921_CR6","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jconrel.2014.03.055","volume":"190","author":"K Forier","year":"2014","unstructured":"Forier K, et al. Lipid and polymer nanoparticles for drug delivery to bacterial biofilms. J Control Release. 2014;190:607\u201323.","journal-title":"J Control Release"},{"key":"921_CR7","doi-asserted-by":"crossref","unstructured":"Canaparo R, et al. Recent Developments in Antibacterial Therapy: Focus on stimuli-responsive drug-delivery systems and therapeutic nanoparticles. Molecules. 2019;24(10)","DOI":"10.3390\/molecules24101991"},{"issue":"1","key":"921_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s13346-016-0349-0","volume":"7","author":"K Dua","year":"2017","unstructured":"Dua K, et al. Whether a novel drug delivery system can overcome the problem of biofilms in respiratory diseases? Drug Deliv Transl Res. 2017;7(1):179\u201387.","journal-title":"Drug Deliv Transl Res"},{"key":"921_CR9","doi-asserted-by":"crossref","unstructured":"Lee NY, Ko WC, Hsueh PR.\u00a0Nanoparticles in the Treatment of infections caused by multidrug-resistant Organisms. Front Pharmacol. 2019;0(1153).","DOI":"10.3389\/fphar.2019.01153"},{"issue":"2","key":"921_CR10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/antibiotics8020054","volume":"8","author":"S Bongers","year":"2019","unstructured":"Bongers S, et al. Intracellular penetration and effects of antibiotics on Staphylococcus aureus inside human neutrophils: a comprehensive review. Antibiotics. 2019;8(2):54.","journal-title":"Antibiotics"},{"key":"921_CR11","doi-asserted-by":"crossref","unstructured":"Baptista PV, et al.\u00a0Nano-Strategies to Fight Multidrug Resistant Bacteria\u2014\u201cA Battle of the Titans\u201d. Frontiers in Microbiology. 2018;9(1441).","DOI":"10.3389\/fmicb.2018.01441"},{"key":"921_CR12","doi-asserted-by":"publisher","first-page":"5687","DOI":"10.2147\/IJN.S139625","volume":"12","author":"A Umerska","year":"2017","unstructured":"Umerska A, et al. Synergistic interactions between antimicrobial peptides derived from plectasin and lipid nanocapsules containing monolaurin as a cosurfactant against Staphylococcus aureus. Int J Nanomed. 2017;12:5687\u201399.","journal-title":"Int J Nanomed"},{"issue":"6","key":"921_CR13","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1007\/s00253-009-2355-3","volume":"85","author":"AP Desbois","year":"2010","unstructured":"Desbois AP, Smith VJ. Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential. Appl Microbiol Biotechnol. 2010;85(6):1629\u201342.","journal-title":"Appl Microbiol Biotechnol"},{"key":"921_CR14","doi-asserted-by":"crossref","unstructured":"Flemming HC, et al.\u00a0Biofilms: an emergent form of bacterial life. 2016;14: p. 563.","DOI":"10.1038\/nrmicro.2016.94"},{"key":"921_CR15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ebiom.2016.09.015","volume":"12","author":"SC Mansour","year":"2016","unstructured":"Mansour SC, et al. Bacterial abscess formation is controlled by the stringent stress response and can be targeted therapeutically. EBioMedicine. 2016;12:219\u201326.","journal-title":"EBioMedicine"},{"key":"921_CR16","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1146\/annurev.mi.49.100195.003431","volume":"49","author":"JW Costerton","year":"1995","unstructured":"Costerton JW, et al. Microbial biofilms. Annu Rev Microbiol. 1995;49:711\u201345.","journal-title":"Annu Rev Microbiol"},{"issue":"5","key":"921_CR17","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nrmicro.2016.34","volume":"14","author":"A Brauner","year":"2016","unstructured":"Brauner A, et al. Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nat Rev Micro. 2016;14(5):320\u201330.","journal-title":"Nat Rev Micro"},{"issue":"19","key":"921_CR18","doi-asserted-by":"publisher","first-page":"6136","DOI":"10.1128\/AEM.01953-14","volume":"80","author":"VO Silva","year":"2014","unstructured":"Silva VO, et al. Biofilm formation on biotic and abiotic surfaces in the presence of antimicrobials by Escherichia coli Isolates from cases of bovine mastitis. Appl Environ Microbiol. 2014;80(19):6136\u201345.","journal-title":"Appl Environ Microbiol"},{"key":"921_CR19","unstructured":"World Health Organisation: Geneva. 2017."},{"issue":"2","key":"921_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S1526-0550(02)00003-3","volume":"3","author":"JC Davies","year":"2002","unstructured":"Davies JC. Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence. Paediatr Respir Rev. 2002;3(2):128\u201334.","journal-title":"Paediatr Respir Rev"},{"issue":"2","key":"921_CR21","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.chembiol.2015.01.002","volume":"22","author":"C de la Fuente-Nunez","year":"2015","unstructured":"de la Fuente-Nunez C, et al. D-enantiomeric peptides that eradicate wild-type and multidrug-resistant biofilms and protect against lethal Pseudomonas aeruginosa infections. Chem Biol. 2015;22(2):196\u2013205.","journal-title":"Chem Biol"},{"issue":"5","key":"921_CR22","doi-asserted-by":"publisher","first-page":"e1004152","DOI":"10.1371\/journal.ppat.1004152","volume":"10","author":"C de la Fuente-N\u00fa\u00f1ez","year":"2014","unstructured":"de la Fuente-N\u00fa\u00f1ez C, et al. Broad-spectrum anti-biofilm peptide that targets a cellular stress response. PLoS Pathog. 2014;10(5):e1004152.","journal-title":"PLoS Pathog"},{"issue":"19","key":"921_CR23","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1128\/JB.00017-16","volume":"198","author":"D Pletzer","year":"2016","unstructured":"Pletzer D, Hancock REW. Antibiofilm peptides: potential as broad-spectrum agents. J Bacteriol. 2016;198(19):2572\u20138.","journal-title":"J Bacteriol"},{"issue":"18","key":"921_CR24","doi-asserted-by":"publisher","first-page":"5376","DOI":"10.1128\/JB.183.18.5376-5384.2001","volume":"183","author":"C van Delden","year":"2001","unstructured":"van Delden C, et al. Stringent response activates quorum sensing and modulates cell density-dependent gene expression Pseudomonas aeruginosa. J Bacteriol. 2001;183(18):5376.","journal-title":"J Bacteriol"},{"issue":"10","key":"921_CR25","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1128\/jb.179.10.3127-3132.1997","volume":"179","author":"EC Pesci","year":"1997","unstructured":"Pesci EC, et al. Regulation of las and rhl quorum sensing in Pseudomonas aeruginosa. J Bacteriol. 1997;179(10):3127\u201332.","journal-title":"J Bacteriol"},{"issue":"9","key":"921_CR26","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nrmicro.2016.89","volume":"14","author":"K Papenfort","year":"2016","unstructured":"Papenfort K, Bassler BL. Quorum sensing signal-response systems in Gram-negative bacteria. Nat Rev Microbiol. 2016;14(9):576\u201388.","journal-title":"Nat Rev Microbiol"},{"key":"921_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1146\/annurev.micro.55.1.165","volume":"55","author":"MB Miller","year":"2001","unstructured":"Miller MB, Bassler BL. Quorum sensing in bacteria. Annu Rev Microbiol. 2001;55:165\u201399.","journal-title":"Annu Rev Microbiol"},{"key":"921_CR28","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3389\/fimmu.2013.00344","volume":"4","author":"J Ferrand","year":"2013","unstructured":"Ferrand J, Ferrero RL. Recognition of extracellular bacteria by NLRs and its role in the development of adaptive immunity. Front immunol. 2013;4:344\u2013344.","journal-title":"Front immunol"},{"key":"921_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fcimb.2012.00043","volume":"2","author":"M Fraunholz","year":"2012","unstructured":"Fraunholz M, Sinha B. Intracellular Staphylococcus aureus: live-in and let die. Front Cell Infec Microbiol. 2012;2:43.","journal-title":"Front Cell Infec Microbiol"},{"issue":"2","key":"921_CR30","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ijmm.2013.11.011","volume":"304","author":"B L\u00f6ffler","year":"2014","unstructured":"L\u00f6ffler B, et al. Staphylococcus aureus persistence in non-professional phagocytes. Int J Med Microbiol. 2014;304(2):170\u20136.","journal-title":"Int J Med Microbiol"},{"issue":"8","key":"921_CR31","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1086\/533452","volume":"197","author":"LB Rice","year":"2008","unstructured":"Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis. 2008;197(8):1079\u201381.","journal-title":"J Infect Dis"},{"key":"921_CR32","doi-asserted-by":"publisher","first-page":"2475067","DOI":"10.1155\/2016\/2475067","volume":"2016","author":"S Santajit","year":"2016","unstructured":"Santajit S, Indrawattana N. Mechanisms of antimicrobial resistance in ESKAPE pathogens. Biomed Res Int. 2016;2016:2475067.","journal-title":"Biomed Res Int"},{"key":"921_CR33","doi-asserted-by":"publisher","unstructured":"Munita JM, Arias CA.\u00a0Mechanisms of Antibiotic Resistance. Microbiology Spectrum. 2016;4(2): p. https:\/\/doi.org\/10.1128\/microbiolspec.VMBF-0016-2015.","DOI":"10.1128\/microbiolspec.VMBF-0016-2015"},{"issue":"1","key":"921_CR34","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrmicro3380","volume":"13","author":"JMA Blair","year":"2015","unstructured":"Blair JMA, et al. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol. 2015;13(1):42\u201351.","journal-title":"Nat Rev Microbiol"},{"key":"921_CR35","unstructured":"O\u2019Neill J. Antimicrobial Resistance: Tackling a crisis for the health and wealth of nations, in the review on antimicrobial resistance. 2014; p. 1\u201316."},{"issue":"10","key":"921_CR36","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1016\/j.xphs.2017.04.068","volume":"106","author":"D Thambavita","year":"2017","unstructured":"Thambavita D, et al. Biowaiver monograph for immediate-release solid oral dosage forms: amoxicillin trihydrate. J Pharm Sci. 2017;106(10):2930\u201345.","journal-title":"J Pharm Sci"},{"issue":"2","key":"921_CR37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/wer.1237","volume":"92","author":"E Jafari Ozumchelouei","year":"2020","unstructured":"Jafari Ozumchelouei E, et al. Physicochemical properties of antibiotics: a review with an emphasis on detection in the aquatic environment. Water Environ Res. 2020;92(2):177\u201388.","journal-title":"Water Environ Res"},{"key":"921_CR38","doi-asserted-by":"crossref","unstructured":"delMoral-Sanchez JM, et al.\u00a0Classification of WHO essential oral medicines for children applying a provisional pediatric biopharmaceutics classification system. Pharmaceutics. 2019;11(11).","DOI":"10.3390\/pharmaceutics11110567"},{"key":"921_CR39","volume-title":"Berlin","author":"REW Hancock","year":"1989","unstructured":"Hancock REW, Bell A, Uptakeinto Gram-Negative Bacteria. A. Berlin. Heidelberg: Springer, Berlin Heidelberg; 1989."},{"key":"921_CR40","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/82_2016_491","volume-title":"How to overcome the antibiotic crisis : Facts, challenges, technologies and future perspectives","author":"F Graef","year":"2016","unstructured":"Graef F, Gordon S, Lehr CM. Anti-infectives in drug delivery\u2014overcoming the gram-negative bacterial cell envelope. In: Stadler M, Dersch P, editors. How to overcome the antibiotic crisis\u202f: Facts, challenges, technologies and future perspectives. Cham: Springer International Publishing; 2016. p. 475\u201396."},{"issue":"1","key":"921_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10408418609108734","volume":"13","author":"T Nakae","year":"1986","unstructured":"Nakae T. Outer-membrane permeability of bacteria. CRC Crit Rev Microbiol. 1986;13(1):1\u201362.","journal-title":"CRC Crit Rev Microbiol"},{"issue":"5","key":"921_CR42","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1001\/archinte.1991.00400050040010","volume":"151","author":"LA Dever","year":"1991","unstructured":"Dever LA, Dermody TS. Mechanisms of bacterial resistance to antibiotics. Arch Intern Med. 1991;151(5):886\u201395.","journal-title":"Arch Intern Med"},{"issue":"12","key":"921_CR43","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/nrmicro1994","volume":"6","author":"JM Pag\u00e8s","year":"2008","unstructured":"Pag\u00e8s JM, James CE, Winterhalter M. The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria. Nat Rev Microbiol. 2008;6(12):893\u2013903.","journal-title":"Nat Rev Microbiol"},{"key":"921_CR44","doi-asserted-by":"crossref","unstructured":"Cowan T.\u00a0Biofilms and their management: from concept to clinical reality. J Wound Care. 2011;20(5): p. 220, 222\u20136.","DOI":"10.12968\/jowc.2011.20.5.220"},{"key":"921_CR45","doi-asserted-by":"crossref","unstructured":"Lewis R. The rise of antibiotic-resistant infections. FDA consumer magazine. 1995;29(1).","DOI":"10.1037\/e548882006-002"},{"issue":"1","key":"921_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41120-015-0002-x","volume":"2","author":"JE Hastedt","year":"2016","unstructured":"Hastedt JE, et al. Scope and relevance of a pulmonary biopharmaceutical classification system AAPS\/FDA\/USP Workshop March 16\u201317th, 2015 in Baltimore, MD. AAPS Open. 2016;2(1):1.","journal-title":"AAPS Open"},{"issue":"1","key":"921_CR47","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijpharm.2015.06.011","volume":"491","author":"VP Shah","year":"2015","unstructured":"Shah VP, et al. A science based approach to topical drug classification system (TCS). Int J Pharm. 2015;491(1):21\u20135.","journal-title":"Int J Pharm"},{"issue":"23","key":"921_CR48","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1056\/NEJMra0910061","volume":"363","author":"JV Fahy","year":"2010","unstructured":"Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl J Med. 2010;363(23):2233\u201347.","journal-title":"N Engl J Med"},{"issue":"10","key":"921_CR49","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1111\/1462-2920.12155","volume":"15","author":"BS Tseng","year":"2013","unstructured":"Tseng BS, et al. The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin. Environ Microbiol. 2013;15(10):2865\u201378.","journal-title":"Environ Microbiol"},{"issue":"2","key":"921_CR50","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/jac\/dkp165","volume":"64","author":"M Alipour","year":"2009","unstructured":"Alipour M, Suntres ZE, Omri A. Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa. J Antimicrob Chemother. 2009;64(2):317\u201325.","journal-title":"J Antimicrob Chemother"},{"key":"921_CR51","first-page":"343","volume":"7","author":"JA Justo","year":"2014","unstructured":"Justo JA, Bookstaver B. Antibiotic lock therapy: review of technique and logistical challenges. Infection and Drug Resistance. 2014;7:343\u201363.","journal-title":"Infection and Drug Resistance"},{"issue":"9","key":"921_CR52","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1093\/jac\/dkq257","volume":"65","author":"R Singh","year":"2010","unstructured":"Singh R, et al. Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms. J Antimicrob Chemother. 2010;65(9):1955\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"921_CR53","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrmicro2415","volume":"8","author":"HC Flemming","year":"2010","unstructured":"Flemming HC, Wingender J. The biofilm matrix. Nat Rev Microbiol. 2010;8(9):623\u201333.","journal-title":"Nat Rev Microbiol"},{"key":"921_CR54","unstructured":"Tanford C.\u00a0The hydrophobic effect: formation of micelles and biological membranes 2d ed. 1980: J. Wiley."},{"key":"921_CR55","first-page":"299","volume":"2","author":"ST Hyde","year":"2001","unstructured":"Hyde ST. Identification of lyotropic liquid crystalline mesophases. Handbook of Applied Surface and Colloid Chemistry. 2001;2:299\u2013332.","journal-title":"Handbook of Applied Surface and Colloid Chemistry"},{"key":"921_CR56","doi-asserted-by":"crossref","unstructured":"Cronan Jr, JE, Gelmann EP.\u00a0Physical properties of membrane lipids: biological relevance and regulation. Bacteriol Rev. 1975;39(3): p. 232.","DOI":"10.1128\/br.39.3.232-256.1975"},{"issue":"3","key":"921_CR57","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/BF02915334","volume":"45","author":"DM Small","year":"1968","unstructured":"Small DM. A classification of biologic lipids based upon their interaction in aqueous systems. J Am Oil Chem Soc. 1968;45(3):108.","journal-title":"J Am Oil Chem Soc"},{"key":"921_CR58","doi-asserted-by":"crossref","unstructured":"Israelachvili JN, Mitchell DJ, Ninham BW.\u00a0Theory of self-assembly of hydrocarbon amphiphiles into micelles and bilayers. J Chem Soc Faraday Trans 2. 1976;72(0): p. 1525\u20131568.","DOI":"10.1039\/f29767201525"},{"key":"921_CR59","doi-asserted-by":"crossref","unstructured":"Israelachvili JN, Mitchell DJ, Ninham BW.\u00a0Theory of self-assembly of lipid bilayers and vesicles. Biochim Biophys Acta Biomembr. 1977;470(2): p. 185\u2013201.","DOI":"10.1016\/0005-2736(77)90099-2"},{"key":"921_CR60","doi-asserted-by":"crossref","unstructured":"Khalil RA, Al-hakam AZ.\u00a0Theoretical estimation of the critical packing parameter of amphiphilic self-assembled aggregates. App Surf Sci. 2014;318: p. 85\u201389.","DOI":"10.1016\/j.apsusc.2014.01.046"},{"issue":"3","key":"921_CR61","doi-asserted-by":"publisher","first-page":"1801223","DOI":"10.1002\/advs.201801223","volume":"6","author":"A Tan","year":"2019","unstructured":"Tan A, et al. Self-assembled nanostructured lipid systems: is there a link between structure and cytotoxicity? Adv Sci. 2019;6(3):1801223.","journal-title":"Adv Sci"},{"issue":"13","key":"921_CR62","doi-asserted-by":"publisher","first-page":"6998","DOI":"10.1021\/la8005579","volume":"24","author":"Y-D Dong","year":"2008","unstructured":"Dong Y-D, et al. Impurities in commercial phytantriol significantly alter its lyotropic liquid-crystalline phase behavior. Langmuir. 2008;24(13):6998\u20137003.","journal-title":"Langmuir"},{"issue":"23","key":"921_CR63","doi-asserted-by":"publisher","first-page":"9512","DOI":"10.1021\/la061706v","volume":"22","author":"Y-D Dong","year":"2006","unstructured":"Dong Y-D, et al. Bulk and dispersed aqueous phase behavior of phytantriol: effect of vitamin E acetate and F127 polymer on liquid crystal nanostructure. Langmuir. 2006;22(23):9512\u20138.","journal-title":"Langmuir"},{"issue":"1\u20132","key":"921_CR64","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ijpharm.2014.05.044","volume":"471","author":"JD Du","year":"2014","unstructured":"Du JD, et al. A novel approach to enhance the mucoadhesion of lipid drug nanocarriers for improved drug delivery to the buccal mucosa. Int J Pharm. 2014;471(1\u20132):358\u201365.","journal-title":"Int J Pharm"},{"issue":"43","key":"921_CR65","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1039\/b609510k","volume":"8","author":"T Kaasgaard","year":"2006","unstructured":"Kaasgaard T, Drummond CJ. Ordered 2-D and 3-D nanostructured amphiphile self-assembly materials stable in excess solvent. Phys Chem Chem Phys. 2006;8(43):4957\u201375.","journal-title":"Phys Chem Chem Phys"},{"issue":"2","key":"921_CR66","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/pharmaceutics9020012","volume":"9","author":"U Bulbake","year":"2017","unstructured":"Bulbake U, et al. Liposomal formulations in clinical use: an updated review. Pharmaceutics. 2017;9(2):12.","journal-title":"Pharmaceutics"},{"issue":"2","key":"921_CR67","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0378-5173(97)00135-X","volume":"154","author":"A Sharma","year":"1997","unstructured":"Sharma A, Sharma US. Liposomes in drug delivery: progress and limitations. Int J Pharm. 1997;154(2):123\u201340.","journal-title":"Int J Pharm"},{"issue":"10","key":"921_CR68","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1517\/17425247.2010.515584","volume":"7","author":"SB Rizwan","year":"2010","unstructured":"Rizwan SB, et al. Bicontinuous cubic liquid crystals as sustained delivery systems for peptides and proteins. Expert Opin Drug Deliv. 2010;7(10):1133\u201344.","journal-title":"Expert Opin Drug Deliv"},{"issue":"4","key":"921_CR69","doi-asserted-by":"publisher","first-page":"288","DOI":"10.4103\/1735-5362.235156","volume":"13","author":"P Ghasemiyeh","year":"2018","unstructured":"Ghasemiyeh P, Mohammadi-Samani S. Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages. Research in Pharmaceutical Sciences. 2018;13(4):288\u2013303.","journal-title":"Research in Pharmaceutical Sciences"},{"issue":"4","key":"921_CR70","doi-asserted-by":"publisher","first-page":"349","DOI":"10.4103\/0250-474X.57282","volume":"71","author":"S Mukherjee","year":"2009","unstructured":"Mukherjee S, Ray S, Thakur RS. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci. 2009;71(4):349\u201358.","journal-title":"Indian J Pharm Sci"},{"issue":"3","key":"921_CR71","doi-asserted-by":"crossref","first-page":"305","DOI":"10.15171\/apb.2015.043","volume":"5","author":"N Naseri","year":"2015","unstructured":"Naseri N, Valizadeh H, Zakeri-Milani P. Solid lipid nanoparticles and nanostructured lipid carriers: structure. Preparation and Application Advance Pharmaceutical Bulletin. 2015;5(3):305\u201313.","journal-title":"Preparation and Application Advance Pharmaceutical Bulletin"},{"key":"921_CR72","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.addr.2018.11.006","volume":"142","author":"P Joyce","year":"2019","unstructured":"Joyce P, et al. Solidification to improve the biopharmaceutical performance of SEDDS: opportunities and challenges. Adv Drug Deliv Rev. 2019;142:102\u201317.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"921_CR73","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1208\/s12248-015-9824-7","volume":"18","author":"TJ Dening","year":"2016","unstructured":"Dening TJ, et al. Novel nanostructured solid materials for modulating oral drug delivery from solid-state lipid-based drug delivery systems. AAPS J. 2016;18(1):23\u201340.","journal-title":"AAPS J"},{"issue":"1","key":"921_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2009.06.001","volume":"73","author":"S Chakraborty","year":"2009","unstructured":"Chakraborty S, et al. Lipid\u2013an emerging platform for oral delivery of drugs with poor bioavailability. Eur J Pharm Biopharm. 2009;73(1):1\u201315.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"921_CR75","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1124\/pr.112.005660","volume":"65","author":"HD Williams","year":"2013","unstructured":"Williams HD, et al. Strategies to address low drug solubility in discovery and development. Pharmacol Rev. 2013;65(1):315\u2013499.","journal-title":"Pharmacol Rev"},{"issue":"4","key":"921_CR76","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1773-2247(13)50054-2","volume":"23","author":"N Thomas","year":"2013","unstructured":"Thomas N, Rades T, M\u00fcllertz A. Recent developments in oral lipid-based drug delivery. J Drug Delivery Sci Technol. 2013;23(4):375\u201382.","journal-title":"J Drug Delivery Sci Technol"},{"key":"921_CR77","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.colsurfb.2016.03.040","volume":"143","author":"GA Islan","year":"2016","unstructured":"Islan GA, et al. Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and Characterization Colloids Surf B. 2016;143:168\u201376.","journal-title":"Design and Characterization Colloids Surf B"},{"key":"921_CR78","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jconrel.2019.05.011","volume":"304","author":"TNQ Phan","year":"2019","unstructured":"Phan TNQ, Shahzadi I, Bernkop-Schn\u00fcrch A. Hydrophobic ion-pairs and lipid-based nanocarrier systems: the perfect match for delivery of BCS class 3 drugs. J Control Release. 2019;304:146\u201355.","journal-title":"J Control Release"},{"issue":"3","key":"921_CR79","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1080\/1061186X.2019.1681434","volume":"28","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, et al. Antimicrobial lipids in nano-carriers for antibacterial delivery. J Drug Target. 2020;28(3):271\u201381.","journal-title":"J Drug Target"},{"issue":"2","key":"921_CR80","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/pharmaceutics12020142","volume":"12","author":"NE Eleraky","year":"2020","unstructured":"Eleraky NE, et al. Nanomedicine fight against antibacterial resistance: an overview of the recent pharmaceutical innovations. Pharmaceutics. 2020;12(2):142.","journal-title":"Pharmaceutics"},{"key":"921_CR81","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3389\/fchem.2019.00872","volume":"7","author":"DY Wang","year":"2020","unstructured":"Wang DY, et al. Lipid-based antimicrobial delivery-systems for the treatment of bacterial infections. Front Chem. 2020;7:872\u2013872.","journal-title":"Front Chem"},{"issue":"3","key":"921_CR82","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/femsre\/fux003","volume":"41","author":"M Natan","year":"2017","unstructured":"Natan M, Banin E. From Nano to Micro: using nanotechnology to combat microorganisms and their multidrug resistance. FEMS Microbiol Rev. 2017;41(3):302\u201322.","journal-title":"FEMS Microbiol Rev"},{"key":"921_CR83","doi-asserted-by":"crossref","unstructured":"Koo H, et al.\u00a0Targeting microbial biofilms: current and prospective therapeutic strategies. Nat Rev Microbiol. 2017.","DOI":"10.1038\/nrmicro.2017.99"},{"key":"921_CR84","doi-asserted-by":"crossref","unstructured":"Thormar H.\u00a0Antibacterial effects of lipids: Historical review (1881 to 1960), in lipids and essential oils as antimicrobial agents. p. 25\u201345.","DOI":"10.1002\/9780470976623.ch2"},{"issue":"4","key":"921_CR85","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000337927","volume":"25","author":"NK Brogden","year":"2012","unstructured":"Brogden NK, et al. The emerging role of peptides and lipids as antimicrobial epidermal barriers and modulators of local inflammation. Skin Pharmacol Physiol. 2012;25(4):167\u201381.","journal-title":"Skin Pharmacol Physiol"},{"issue":"2","key":"921_CR86","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1128\/br.12.2.105-148.1948","volume":"12","author":"HN Glassman","year":"1948","unstructured":"Glassman HN. Surface active agents and their application in bacteriology. Bacteriol Rev. 1948;12(2):105\u201348.","journal-title":"Bacteriol Rev"},{"issue":"2","key":"921_CR87","first-page":"75","volume":"9","author":"CL Fischer","year":"2020","unstructured":"Fischer CL. Antimicrobial Activity of Host-Derived Lipids Antibiotics. 2020;9(2):75.","journal-title":"Antimicrobial Activity of Host-Derived Lipids Antibiotics"},{"key":"921_CR88","doi-asserted-by":"crossref","unstructured":"Kabara JJ, Vrable R, Lie Ken Jie MSF.\u00a0Antimicrobial lipids: Natural and synthetic fatty acids and monoglycerides. Lipids. 1977;12(9): p. 753\u2013759.","DOI":"10.1007\/BF02570908"},{"key":"921_CR89","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ejpb.2016.09.001","volume":"108","author":"A Umerska","year":"2016","unstructured":"Umerska A, et al. Antibacterial action of lipid nanocapsules containing fatty acids or monoglycerides as co-surfactants. Eur J Pharm Biopharm. 2016;108:100\u201310.","journal-title":"Eur J Pharm Biopharm"},{"issue":"7","key":"921_CR90","doi-asserted-by":"publisher","first-page":"e40350","DOI":"10.1371\/journal.pone.0040350","volume":"7","author":"PM Schlievert","year":"2012","unstructured":"Schlievert PM, Peterson ML. Glycerol monolaurate antibacterial activity in broth and biofilm cultures. PLoS One. 2012;7(7):e40350.","journal-title":"PLoS One"},{"issue":"3","key":"921_CR91","doi-asserted-by":"publisher","first-page":"e0120280","DOI":"10.1371\/journal.pone.0120280","volume":"10","author":"EA Mueller","year":"2015","unstructured":"Mueller EA, Schlievert PM. Non-aqueous glycerol monolaurate gel exhibits antibacterial and anti-biofilm activity against Gram-positive and Gram-negative pathogens. PLoS One. 2015;10(3):e0120280.","journal-title":"PLoS One"},{"key":"921_CR92","unstructured":"Science, H.L. Pipeline: Human Health Initiatives. 2017;[20 April 2020]. Available from: http:\/\/www.hennepinlifesciences.com\/human\/."},{"key":"921_CR93","unstructured":"Thomas ND, Richter K, Prestidge CA.\u00a0Antimicrobial compositions and methods of use. Filed 2018, issued 2019."},{"issue":"5","key":"921_CR94","first-page":"4328","volume":"14","author":"W Chanda","year":"2017","unstructured":"Chanda W, et al. Combined effect of linolenic acid and tobramycin on Pseudomonas aeruginosa biofilm formation and quorum sensing. Exp Ther Med. 2017;14(5):4328\u201338.","journal-title":"Exp Ther Med"},{"issue":"9","key":"921_CR95","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1021\/mp300243w","volume":"9","author":"M Obonyo","year":"2012","unstructured":"Obonyo M, et al. Antibacterial activities of liposomal linolenic acids against antibiotic-resistant Helicobacter pylori. Mol Pharm. 2012;9(9):2677\u201385.","journal-title":"Mol Pharm"},{"issue":"1","key":"921_CR96","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.biomaterials.2010.08.076","volume":"32","author":"C-M Huang","year":"2011","unstructured":"Huang C-M, et al. Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids. Biomaterials. 2011;32(1):214\u201321.","journal-title":"Biomaterials"},{"issue":"4","key":"921_CR97","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1631\/jzus.B1700063","volume":"19","author":"W Chanda","year":"2018","unstructured":"Chanda W, et al. Effectiveness of omega-3 polyunsaturated fatty acids against microbial pathogens. J Zhejiang Univ Sci B. 2018;19(4):253\u201362.","journal-title":"J Zhejiang Univ Sci B"},{"key":"921_CR98","unstructured":"Mendrok-Edinger C, Mongiat SRT, Schlifke-Poschalko A.\u00a0Use of Phytantriol as an Antimicrobial Agent, DSM, Editor. 2017."},{"issue":"2","key":"921_CR99","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jconrel.2004.06.013","volume":"99","author":"GA Kossena","year":"2004","unstructured":"Kossena GA, et al. A novel cubic phase of medium chain lipid origin for the delivery of poorly water soluble drugs. J Control Release. 2004;99(2):217\u201329.","journal-title":"J Control Release"},{"issue":"5","key":"921_CR100","doi-asserted-by":"publisher","first-page":"310","DOI":"10.4103\/0972-5229.132495","volume":"18","author":"A Ahmed","year":"2014","unstructured":"Ahmed A, et al. Current concepts in combination antibiotic therapy for critically ill patients. Indian Journal of Critical Care Medicine. 2014;18(5):310\u20134.","journal-title":"Indian Journal of Critical Care Medicine"},{"issue":"1","key":"921_CR101","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/14787210.2020.1705155","volume":"18","author":"ARM Coates","year":"2020","unstructured":"Coates ARM, et al. Antibiotic combination therapy against resistant bacterial infections: synergy, rejuvenation and resistance reduction. Expert Rev Anti-Infect Ther. 2020;18(1):5\u201315.","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"8","key":"921_CR102","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1167\/iovs.09-4839","volume":"51","author":"H Sueke","year":"2010","unstructured":"Sueke H, et al. An in vitro investigation of synergy or antagonism between antimicrobial combinations against isolates from bacterial keratitis. Invest Ophthalmol Vis Sci. 2010;51(8):4151\u20135.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"921_CR103","doi-asserted-by":"crossref","unstructured":"H\u00e5kansson J, et al. Characterization of the in vitro, ex vivo, and in vivo Efficacy of the Antimicrobial Peptide DPK-060 Used for Topical Treatment. Front Cell Infect Microbiol. 2019;9(174).","DOI":"10.3389\/fcimb.2019.00174"},{"key":"921_CR104","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jconrel.2014.06.055","volume":"192","author":"N Nafee","year":"2014","unstructured":"Nafee N, et al. Antibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors. J Control Release. 2014;192:131\u201340.","journal-title":"J Control Release"},{"issue":"6","key":"921_CR105","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.ijantimicag.2015.01.016","volume":"45","author":"D Nicolosi","year":"2015","unstructured":"Nicolosi D, et al. Nanotechnology approaches for antibacterial drug delivery: preparation and microbiological evaluation of fusogenic liposomes carrying fusidic acid. Int J Antimicrob Agents. 2015;45(6):622\u20136.","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"921_CR106","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S1773-2247(11)50076-0","volume":"21","author":"E Ducat","year":"2011","unstructured":"Ducat E, et al. Cellular uptake of liposomes monitored by confocal microscopy and flow cytometry. J Drug Delivery Sci Technol. 2011;21(6):469\u201377.","journal-title":"J Drug Delivery Sci Technol"},{"key":"921_CR107","doi-asserted-by":"crossref","unstructured":"Ellens H, Bentz J, Szoka FC.\u00a0Fusion of phosphatidylethanolamine-containing liposomes and mechanism of L.alpha.-HII phase transition. Biochemistry. 1986;25(14): p. 4141\u20134147.","DOI":"10.1021\/bi00362a023"},{"issue":"4","key":"921_CR108","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0092-8674(03)00112-0","volume":"112","author":"R Jahn","year":"2003","unstructured":"Jahn R, Lang T, S\u00fcdhof TC. Membrane fusion. Cell. 2003;112(4):519\u201333.","journal-title":"Cell"},{"issue":"3","key":"921_CR109","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1021\/acsabm.8b00821","volume":"2","author":"C Zhang","year":"2019","unstructured":"Zhang C, et al. Antibiotic-derived lipid nanoparticles to treat intracellular Staphylococcus aureus. ACS Appl Bio-Mater. 2019;2(3):1270\u20137.","journal-title":"ACS Appl Bio-Mater"},{"issue":"9","key":"921_CR110","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1023\/A:1015885814417","volume":"8","author":"P Couvreur","year":"1991","unstructured":"Couvreur P, Fattal E, Andremont A. Liposomes and nanoparticles in the treatment of intracellular bacterial infections. Pharm Res. 1991;8(9):1079\u201386.","journal-title":"Pharm Res"},{"issue":"5","key":"921_CR111","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s40265-019-01095-z","volume":"79","author":"M Shirley","year":"2019","unstructured":"Shirley M. Amikacin liposome inhalation suspension: a review in Mycobacterium avium complex lung disease. Drugs. 2019;79(5):555\u201362.","journal-title":"Drugs"},{"issue":"2","key":"921_CR112","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S0005-2736(99)00217-5","volume":"1463","author":"S Sachetelli","year":"2000","unstructured":"Sachetelli S, et al. Demonstration of a fusion mechanism between a fluid bactericidal liposomal formulation and bacterial cells. Biochem Biophys Acta. 2000;1463(2):254\u201366.","journal-title":"Biochem Biophys Acta"},{"key":"921_CR113","unstructured":"Jacqueline Lagace CB. S\u00e9bastien Clement-Major, Low rigidity liposomal antibacterial composition, and U.D. Montreal, Editors. 1994: World."},{"issue":"3","key":"921_CR114","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1128\/AAC.40.3.665","volume":"40","author":"C Beaulac","year":"1996","unstructured":"Beaulac C, et al. Eradication of mucoid Pseudomonas aeruginosa with fluid liposome-encapsulated tobramycin in an animal model of chronic pulmonary infection. Antimicrob Agents Chemother. 1996;40(3):665\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"921_CR115","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1128\/AAC.38.5.1090","volume":"38","author":"A Omri","year":"1994","unstructured":"Omri A, et al. Pulmonary retention of free and liposome-encapsulated tobramycin after intratracheal administration in uninfected rats and rats infected with Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1994;38(5):1090\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"921_CR116","unstructured":"AG, AP. Cystic Fibrosis - Orphan drug designation for innovative treatment against lung infections by Axentis Pharma AG. 2009."},{"key":"921_CR117","unstructured":"Barriga HMG, Holme MN, Stevens MM.\u00a0Cubosomes; the next generation of smart lipid nanoparticles? Angewandte Chemie. 0(ja)."},{"issue":"1","key":"921_CR118","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1039\/C3TX50075F","volume":"3","author":"TM Hinton","year":"2014","unstructured":"Hinton TM, et al. Bicontinuous cubic phase nanoparticle lipid chemistry affects toxicity in cultured cells. Toxicol Res. 2014;3(1):11\u201322.","journal-title":"Toxicol Res"},{"issue":"1","key":"921_CR119","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1038\/s41467-019-12508-8","volume":"10","author":"BP Dyett","year":"2019","unstructured":"Dyett BP, et al. Fusion dynamics of cubosome nanocarriers with model cell membranes. Nat Commun. 2019;10(1):4492.","journal-title":"Nat Commun"},{"issue":"36","key":"921_CR120","doi-asserted-by":"publisher","first-page":"9473","DOI":"10.1016\/j.biomaterials.2010.08.030","volume":"31","author":"H-H Shen","year":"2010","unstructured":"Shen H-H, et al. The influence of dipalmitoyl phosphatidylserine on phase behaviour of and cellular response to lyotropic liquid crystalline dispersions. Biomaterials. 2010;31(36):9473\u201381.","journal-title":"Biomaterials"},{"issue":"4","key":"921_CR121","first-page":"255","volume":"42","author":"J Seddon","year":"1992","unstructured":"Seddon J. Inverse cubic phases of membrane-lipids, and their relevance to the static and dynamic structure of biomembranes. Acta Pharm. 1992;42(4):255\u201362.","journal-title":"Acta Pharm"},{"issue":"21","key":"921_CR122","doi-asserted-by":"publisher","first-page":"7304","DOI":"10.1021\/j100358a010","volume":"93","author":"K Larsson","year":"1989","unstructured":"Larsson K. Cubic lipid-water phases: structures and biomembrane aspects. J Phys Chem. 1989;93(21):7304\u201314.","journal-title":"J Phys Chem"},{"issue":"5","key":"921_CR123","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1021\/am2003069","volume":"3","author":"Y-D Dong","year":"2011","unstructured":"Dong Y-D, et al. Adsorption of nonlamellar nanostructured liquid-crystalline particles to biorelevant surfaces for improved delivery of bioactive compounds. ACS Appl Mater Interfaces. 2011;3(5):1771\u201380.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"11","key":"921_CR124","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1111\/j.2042-7158.2012.01535.x","volume":"64","author":"T Rattanapak","year":"2012","unstructured":"Rattanapak T, et al. Comparative study of liposomes, transfersomes, ethosomes and cubosomes for transcutaneous immunisation: characterisation and in vitro skin penetration. J Pharm Pharmacol. 2012;64(11):1560\u20139.","journal-title":"J Pharm Pharmacol"},{"issue":"24","key":"921_CR125","doi-asserted-by":"publisher","first-page":"21314","DOI":"10.1021\/acsami.9b01826","volume":"11","author":"L Boge","year":"2019","unstructured":"Boge L, et al. Peptide-loaded cubosomes functioning as an antimicrobial unit against Escherichia coli. ACS Appl Mater Interfaces. 2019;11(24):21314\u201322.","journal-title":"ACS Appl Mater Interfaces"},{"key":"921_CR126","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jcis.2018.02.048","volume":"519","author":"N Tran","year":"2018","unstructured":"Tran N, et al. Non-lamellar lyotropic liquid crystalline nanoparticles enhance the antibacterial effects of rifampicin against Staphylococcus aureus. J Colloid Interface Sci. 2018;519:107\u201318.","journal-title":"J Colloid Interface Sci"},{"key":"921_CR127","doi-asserted-by":"crossref","unstructured":"Transport of nanoparticles and tobramycin-loaded liposomes in Burkholderia cepacia complex biofilms. PLoS One. 2013;8(11): p. no pagination.","DOI":"10.1371\/journal.pone.0079220"},{"issue":"11","key":"921_CR128","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1002\/anie.201006849","volume":"50","author":"M Yang","year":"2011","unstructured":"Yang M, et al. Biodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus. Angew Chem Int Ed Engl. 2011;50(11):2597\u2013600.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1","key":"921_CR129","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/jac\/41.1.35","volume":"41","author":"C Beaulac","year":"1998","unstructured":"Beaulac C, Sachetelli S, Lagace J. In-vitro bactericidal efficacy of sub-MIC concentrations of liposome-encapsulated antibiotic against gram-negative and gram-positive bacteria. J Antimicrob Chemother. 1998;41(1):35\u201341.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"921_CR130","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1093\/jac\/dkn059","volume":"61","author":"P Meers","year":"2008","unstructured":"Meers P, et al. Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections. J Antimicrob Chemother. 2008;61(4):859\u201368.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"921_CR131","doi-asserted-by":"publisher","first-page":"e0131806","DOI":"10.1371\/journal.pone.0131806","volume":"10","author":"D Dong","year":"2015","unstructured":"Dong D, et al. Distribution and inhibition of liposomes on Staphylococcus aureus and Pseudomonas aeruginosa biofilm. PLoS One. 2015;10(6):e0131806.","journal-title":"PLoS One"},{"issue":"11","key":"921_CR132","doi-asserted-by":"publisher","first-page":"e79220","DOI":"10.1371\/journal.pone.0079220","volume":"8","author":"AS Messiaen","year":"2013","unstructured":"Messiaen AS, et al. Transport of nanoparticles and tobramycin-loaded liposomes in Burkholderia cepacia complex biofilms. PLoS One. 2013;8(11):e79220.","journal-title":"PLoS One"},{"key":"921_CR133","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev-bioeng-062117-121156","volume":"20","author":"TL Carlson","year":"2018","unstructured":"Carlson TL, Lock JY, Carrier RL. Engineering the mucus barrier. Annu Rev Biomed Eng. 2018;20:197\u2013220.","journal-title":"Annu Rev Biomed Eng"},{"key":"921_CR134","doi-asserted-by":"crossref","unstructured":"Torge A, et al.\u00a0Ciprofloxacin-loaded lipid-core nanocapsules as mucus penetrating drug delivery system intended for the treatment of bacterial infections in cystic fibrosis. Int J Pharm. 2017;527.","DOI":"10.1016\/j.ijpharm.2017.05.013"},{"issue":"1","key":"921_CR135","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/cbic.200900557","volume":"11","author":"JG Swoboda","year":"2010","unstructured":"Swoboda JG, et al. Wall teichoic acid function, biosynthesis, and inhibition. Chem Bio Chem. 2010;11(1):35\u201345.","journal-title":"Chem Bio Chem"},{"issue":"5","key":"921_CR136","doi-asserted-by":"publisher","first-page":"a000414","DOI":"10.1101\/cshperspect.a000414","volume":"2","author":"TJ Silhavy","year":"2010","unstructured":"Silhavy TJ, Kahne D, Walker S. The bacterial cell envelope. Cold Spring Harbor Perspect Biol. 2010;2(5):a000414\u2013a000414.","journal-title":"Cold Spring Harbor Perspect Biol"},{"issue":"12","key":"921_CR137","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/nbt1267","volume":"24","author":"REW Hancock","year":"2006","unstructured":"Hancock REW, Sahl H-G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotech. 2006;24(12):1551\u20137.","journal-title":"Nat Biotech"},{"issue":"1","key":"921_CR138","first-page":"126","volume":"121","author":"LA Germoni","year":"2016","unstructured":"Germoni LA, Bremer PJ, Lamont IL. The effect of alginate lyase on the gentamicin resistance of Pseudomonas aeruginosa in mucoid biofilms. J Gen Microbiol. 2016;121(1):126\u201335.","journal-title":"J Gen Microbiol"},{"issue":"4","key":"921_CR139","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/jac\/dkm289","volume":"60","author":"M Halwani","year":"2007","unstructured":"Halwani M, et al. Bactericidal efficacy of liposomal aminoglycosides against Burkholderia cenocepacia. J Antimicrob Chemother. 2007;60(4):760\u20139.","journal-title":"J Antimicrob Chemother"},{"issue":"46","key":"921_CR140","doi-asserted-by":"publisher","first-page":"14265","DOI":"10.1021\/la402426y","volume":"29","author":"Q Liu","year":"2013","unstructured":"Liu Q, et al. Sensitivity of nanostructure in charged cubosomes to phase changes triggered by ionic species in solution. Langmuir. 2013;29(46):14265\u201373.","journal-title":"Langmuir"},{"key":"921_CR141","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.2147\/IJN.S36111","volume":"7","author":"E Fr\u00f6hlich","year":"2012","unstructured":"Fr\u00f6hlich E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomed. 2012;7:5577\u201391.","journal-title":"Int J Nanomed"},{"issue":"3","key":"921_CR142","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1021\/nn2000756","volume":"5","author":"O Lunov","year":"2011","unstructured":"Lunov O, et al. Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. ACS Nano. 2011;5(3):1657\u201369.","journal-title":"ACS Nano"},{"key":"921_CR143","doi-asserted-by":"crossref","unstructured":"Boehm F.\u00a0Nanomedical device and systems design: challenges, possibilities, visions. 2016: CRC Press.","DOI":"10.1201\/b15626"},{"issue":"1","key":"921_CR144","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ijpharm.2003.08.017","volume":"269","author":"SP Vyas","year":"2004","unstructured":"Vyas SP, et al. Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. Int J Pharm. 2004;269(1):37\u201349.","journal-title":"Int J Pharm"},{"issue":"2","key":"921_CR145","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.chom.2016.01.001","volume":"19","author":"M Zanin","year":"2016","unstructured":"Zanin M, et al. The interaction between respiratory pathogens and mucus. Cell Host Microbe. 2016;19(2):159\u201368.","journal-title":"Cell Host Microbe"},{"issue":"2","key":"921_CR146","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s13346-011-0048-9","volume":"2","author":"T Yu","year":"2012","unstructured":"Yu T, et al. Biodegradable mucus-penetrating nanoparticles composed of diblock copolymers of polyethylene glycol and poly(lactic-co-glycolic acid). Drug Deliv Transl Res. 2012;2(2):124\u20138.","journal-title":"Drug Deliv Transl Res"},{"issue":"4","key":"921_CR147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22159\/ijcpr.2017v9i4.20960","volume":"9","author":"Mucoadhesive buccal drug delivery system","year":"2017","unstructured":"Mucoadhesive buccal drug delivery system. Review article. Int J Curr Pharm Res. 2017;9(4):1\u20134.","journal-title":"Int J Curr Pharm Res"},{"issue":"4","key":"921_CR148","doi-asserted-by":"publisher","first-page":"e1601556","DOI":"10.1126\/sciadv.1601556","volume":"3","author":"CS Schneider","year":"2017","unstructured":"Schneider CS, et al. Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation. Sci Adv. 2017;3(4):e1601556.","journal-title":"Sci Adv"},{"issue":"19","key":"921_CR149","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.1021\/la010161w","volume":"17","author":"PT Spicer","year":"2001","unstructured":"Spicer PT, et al. Novel process for producing cubic liquid crystalline nanoparticles (cubosomes). Langmuir. 2001;17(19):5748\u201356.","journal-title":"Langmuir"},{"key":"921_CR150","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejpb.2017.12.017","volume":"124","author":"N Nafee","year":"2018","unstructured":"Nafee N, et al. Mucus-penetrating solid lipid nanoparticles for the treatment of cystic fibrosis: proof of concept, challenges and pitfalls. Eur J Pharm Biopharm. 2018;124:125\u201337.","journal-title":"Eur J Pharm Biopharm"},{"key":"921_CR151","first-page":"e3857","volume":"64","author":"S Kirchner","year":"2012","unstructured":"Kirchner S, et al. Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung. J Visualized Exp. 2012;64:e3857.","journal-title":"J Visualized Exp"},{"issue":"9","key":"921_CR152","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1021\/acs.biomac.9b00780","volume":"20","author":"BC Huck","year":"2019","unstructured":"Huck BC, et al. Macro- and microrheological properties of mucus surrogates in comparison to native intestinal and pulmonary mucus. Biomacromol. 2019;20(9):3504\u201312.","journal-title":"Biomacromol"},{"issue":"1","key":"921_CR153","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ijpharm.2015.12.028","volume":"498","author":"M Moreno-Sastre","year":"2016","unstructured":"Moreno-Sastre M, et al. Pulmonary delivery of tobramycin-loaded nanostructured lipid carriers for Pseudomonas aeruginosa infections associated with cystic fibrosis. Int J Pharm. 2016;498(1):263\u201373.","journal-title":"Int J Pharm"},{"key":"921_CR154","doi-asserted-by":"crossref","unstructured":"Nielsen LS, Schubert L, Hansen J. Bioadhesive drug delivery systems: I. Characterisation of mucoadhesive properties of systems based on glyceryl mono-oleate and glyceryl monolinoleate. Eur J Pharm Sci. 1998;6(3): p. 231\u2013239.","DOI":"10.1016\/S0928-0987(97)10004-5"},{"issue":"6","key":"921_CR155","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s13346-011-0045-z","volume":"1","author":"TH Nguyen","year":"2011","unstructured":"Nguyen TH, et al. Nanostructured reverse hexagonal liquid crystals sustain plasma concentrations for a poorly water-soluble drug after oral administration. Drug Deliv Transl Res. 2011;1(6):429\u201338.","journal-title":"Drug Deliv Transl Res"},{"issue":"12","key":"921_CR156","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1007\/s11095-007-9409-y","volume":"24","author":"NK Swarnakar","year":"2007","unstructured":"Swarnakar NK, et al. Enhanced oromucosal delivery of progesterone via hexosomes. Pharm Res. 2007;24(12):2223\u201330.","journal-title":"Pharm Res"},{"key":"921_CR157","volume-title":"and H","author":"A Popov","year":"2018","unstructured":"Popov A, Enlow EM. and H. Particles, compositions and methods for ophthalmic and\/or other applications: Chen; 2018."},{"key":"921_CR158","doi-asserted-by":"crossref","unstructured":"Torchilin VP. Passive and active drug targeting: Drug delivery to tumors as an example, in drug delivery, M. Sch\u00e4fer-Korting, Editor. 2010, Springer Berlin Heidelberg: Berlin, Heidelberg. p. 3\u201353.","DOI":"10.1007\/978-3-642-00477-3_1"},{"key":"921_CR159","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-bioeng-071811-150124","volume":"14","author":"A Albanese","year":"2012","unstructured":"Albanese A, Tang PS, Chan WC. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng. 2012;14:1\u201316.","journal-title":"Annu Rev Biomed Eng"},{"issue":"2","key":"921_CR160","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ijpharm.2017.11.064","volume":"544","author":"J Yu","year":"2018","unstructured":"Yu J, et al. Advances in bioresponsive closed-loop drug delivery systems. Int J Pharm. 2018;544(2):350\u20137.","journal-title":"Int J Pharm"},{"issue":"4","key":"921_CR161","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1586\/17476348.2014.918507","volume":"8","author":"V Waters","year":"2014","unstructured":"Waters V, Ratjen F. Inhaled liposomal amikacin. Expert Rev Respir Med. 2014;8(4):401\u20139.","journal-title":"Expert Rev Respir Med"},{"issue":"9","key":"921_CR162","doi-asserted-by":"publisher","first-page":"e1006452","DOI":"10.1371\/journal.ppat.1006452","volume":"13","author":"JK Rudkin","year":"2017","unstructured":"Rudkin JK, et al. Bacterial toxins: offensive, defensive, or something else altogether? PLoS Pathog. 2017;13(9):e1006452.","journal-title":"PLoS Pathog"},{"key":"921_CR163","unstructured":"Shorrock SM, Kun S, Peura R. The exploration of tissue pH in wounds and its relationship to bacterial contamination. Master Degree Thesis. 2000: p. 20\u201324."},{"issue":"4","key":"921_CR164","first-page":"201","volume":"10","author":"CA Dinarello","year":"2004","unstructured":"Dinarello CA. Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J Endotoxin Res. 2004;10(4):201\u201322.","journal-title":"J Endotoxin Res"},{"key":"921_CR165","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/B978-0-323-07447-6.00011-9","volume-title":"Elsevier's Integrated Review Immunology and Microbiology (Second Edition)","author":"JK Actor","year":"2012","unstructured":"Actor JK. 11 - Basic Bacteriology. In: Actor JK, editor. Elsevier\u2019s Integrated Review Immunology and Microbiology (Second Edition). Philadelphia: W.B. Saunders; 2012. p. 93\u2013103."},{"key":"921_CR166","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.toxicon.2017.10.016","volume":"149","author":"J-M Cavaillon","year":"2018","unstructured":"Cavaillon J-M. Exotoxins and endotoxins: inducers of inflammatory cytokines. Toxicon. 2018;149:45\u201353.","journal-title":"Toxicon"},{"issue":"13","key":"921_CR167","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/S1286-4579(99)00205-1","volume":"1","author":"DH Schmiel","year":"1999","unstructured":"Schmiel DH, Miller VL. Bacterial phospholipases and pathogenesis. Microbes Infect. 1999;1(13):1103\u201312.","journal-title":"Microbes Infect"},{"issue":"1","key":"921_CR168","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1574-6976.1994.tb00121.x","volume":"15","author":"KE Jaeger","year":"1994","unstructured":"Jaeger KE, et al. Bacterial lipases. FEMS Microbiol Rev. 1994;15(1):29\u201363.","journal-title":"FEMS Microbiol Rev"},{"issue":"5","key":"921_CR169","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/j.actbio.2014.01.009","volume":"10","author":"MC Coll Ferrer","year":"2014","unstructured":"Coll Ferrer MC, et al. Designing nanogel carriers for antibacterial applications. Acta Biomater. 2014;10(5):2105\u201311.","journal-title":"Acta Biomater"},{"issue":"11","key":"921_CR170","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.1021\/ja111110e","volume":"133","author":"D Pornpattananangkul","year":"2011","unstructured":"Pornpattananangkul D, et al. Bacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection. J Am Chem Soc. 2011;133(11):4132\u20139.","journal-title":"J Am Chem Soc"},{"issue":"17","key":"921_CR171","doi-asserted-by":"publisher","first-page":"14299","DOI":"10.1021\/acsami.7b15678","volume":"10","author":"S Yang","year":"2018","unstructured":"Yang S, et al. Bacteria-targeting nanoparticles with microenvironment-responsive antibiotic release to eliminate intracellular Staphylococcus aureus and associated infection. ACS Appl Mater Interfaces. 2018;10(17):14299\u2013311.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"2","key":"921_CR172","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1021\/acsabm.8b00062","volume":"1","author":"CR Thorn","year":"2018","unstructured":"Thorn CR, et al. Pseudomonas infection responsive liquid crystals for glycoside hydrolase and antibiotic combination. ACS Applied Bio Mat. 2018;1(2):281\u20138.","journal-title":"ACS Applied Bio Mat"},{"key":"921_CR173","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jconrel.2019.12.037","volume":"319","author":"CR Thorn","year":"2020","unstructured":"Thorn CR, et al. Bacterial lipase triggers the release of antibiotics from digestible liquid crystal nanoparticles. J Control Release. 2020;319:168\u201382.","journal-title":"J Control Release"},{"issue":"46","key":"921_CR174","doi-asserted-by":"publisher","first-page":"8201","DOI":"10.1039\/C4TB01110D","volume":"2","author":"S Thamphiwatana","year":"2014","unstructured":"Thamphiwatana S, et al. Phospholipase A2-responsive antibiotic delivery via nanoparticle-stabilized liposomes for the treatment of bacterial infection. J Mater Chem B. 2014;2(46):8201\u20137.","journal-title":"J Mater Chem B"},{"key":"921_CR175","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.chemphyslip.2017.12.007","volume":"212","author":"M Jadhav","year":"2018","unstructured":"Jadhav M, et al. Novel lipids with three C18-fatty acid chains and an amino acid head group for pH-responsive and sustained antibiotic delivery. Chem Phys Lipids. 2018;212:12\u201325.","journal-title":"Chem Phys Lipids"},{"issue":"1\u20132","key":"921_CR176","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s12013-017-0786-5","volume":"76","author":"S Ahmed","year":"2018","unstructured":"Ahmed S, et al. Identifying the interaction of vancomycin with novel pH-responsive lipids as antibacterial biomaterials via accelerated molecular dynamics and binding free energy calculations. Cell Biochem Biophys. 2018;76(1\u20132):147\u201359.","journal-title":"Cell Biochem Biophys"},{"issue":"6","key":"921_CR177","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1016\/j.nano.2017.04.010","volume":"13","author":"RS Kalhapure","year":"2017","unstructured":"Kalhapure RS, et al. Enhancing targeted antibiotic therapy via pH responsive solid lipid nanoparticles from an acid cleavable lipid. Nanomedicine. 2017;13(6):2067\u201377.","journal-title":"Nanomedicine"},{"issue":"30","key":"921_CR178","doi-asserted-by":"publisher","first-page":"6671","DOI":"10.1039\/C4CC10274F","volume":"51","author":"R Negrini","year":"2015","unstructured":"Negrini R, et al. pH-responsive lyotropic liquid crystals and their potential therapeutic role in cancer treatment. Chem Commun (Camb). 2015;51(30):6671\u20134.","journal-title":"Chem Commun (Camb)"},{"issue":"1","key":"921_CR179","first-page":"241","volume":"495","author":"NB Bisset","year":"2015","unstructured":"Bisset NB, Boyd BJ, Dong YD. Tailoring liquid crystalline lipid nanomaterials for controlled release of macromolecules. Int J Pharm Res. 2015;495(1):241\u20138.","journal-title":"Int J Pharm Res"},{"issue":"9","key":"921_CR180","doi-asserted-by":"publisher","first-page":"5296","DOI":"10.1021\/la200591u","volume":"27","author":"R Negrini","year":"2011","unstructured":"Negrini R, Mezzenga R. pH-responsive lyotropic liquid crystals for controlled drug delivery. Langmuir. 2011;27(9):5296\u2013303.","journal-title":"Langmuir"},{"key":"921_CR181","doi-asserted-by":"crossref","unstructured":"Bender J, Flieger A.\u00a0Lipases as pathogenicity factors of bacterial pathogens of humans, in handbook of hydrocarbon and lipid microbiology, Timmis KN, Editor. 2010. Springer Berlin Heidelberg: Berlin, Heidelberg. p. 3241\u20133258.","DOI":"10.1007\/978-3-540-77587-4_246"},{"key":"921_CR182","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cis.2008.06.001","volume":"147\u2013148","author":"P Reis","year":"2009","unstructured":"Reis P, et al. Lipases at interfaces: a review. Adv Colloid Interface Sci. 2009;147\u2013148:237\u201350.","journal-title":"Adv Colloid Interface Sci"},{"issue":"3","key":"921_CR183","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S0022-2275(20)40211-1","volume":"5","author":"JA Alford","year":"1964","unstructured":"Alford JA, Pierce DA, Suggs FG. Activity of microbial lipases on natural fats and synthetic triglycerides. J Lipid Res. 1964;5(3):390\u20134.","journal-title":"J Lipid Res"},{"issue":"24","key":"921_CR184","doi-asserted-by":"publisher","first-page":"6933","DOI":"10.1021\/acs.langmuir.5b01615","volume":"31","author":"L Hong","year":"2015","unstructured":"Hong L, et al. Understanding the mechanism of enzyme-induced formation of lyotropic liquid crystalline nanoparticles. Langmuir. 2015;31(24):6933\u201341.","journal-title":"Langmuir"},{"issue":"1","key":"921_CR185","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1021\/acs.molpharmaceut.5b00784","volume":"13","author":"AC Pham","year":"2016","unstructured":"Pham AC, et al. In vivo formation of cubic phase in situ after oral administration of cubic phase precursor formulation provides long duration gastric retention and absorption for poorly water-soluble drugs. Mol Pharm. 2016;13(1):280\u20136.","journal-title":"Mol Pharm"},{"issue":"1","key":"921_CR186","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ijpharm.2012.08.018","volume":"437","author":"J Parmentier","year":"2012","unstructured":"Parmentier J, et al. Exploring the fate of liposomes in the intestine by dynamic in vitro lipolysis. Int J Pharm. 2012;437(1):253\u201363.","journal-title":"Int J Pharm"},{"issue":"6","key":"921_CR187","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S1359-0294(00)00020-0","volume":"4","author":"CJ Drummond","year":"1999","unstructured":"Drummond CJ, Fong C. Surfactant self-assembly objects as novel drug delivery vehicles. Curr Opin Colloid Interface Sci. 1999;4(6):449\u201356.","journal-title":"Curr Opin Colloid Interface Sci"},{"issue":"4","key":"921_CR188","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1128\/mr.55.4.733-751.1991","volume":"55","author":"S Bhakdi","year":"1991","unstructured":"Bhakdi S, Tranum-Jensen J. Alpha-toxin of Staphylococcus aureus. Microbiol Rev. 1991;55(4):733\u201351.","journal-title":"Microbiol Rev"},{"issue":"2","key":"921_CR189","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1084\/jem.20072208","volume":"205","author":"JB Wardenburg","year":"2008","unstructured":"Wardenburg JB, Schneewind O. Vaccine protection against Staphylococcus aureus pneumonia. J Exp Med. 2008;205(2):287\u201394.","journal-title":"J Exp Med"},{"issue":"7","key":"921_CR190","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1089\/wound.2014.0538","volume":"4","author":"EM Jones","year":"2015","unstructured":"Jones EM, Cochrane CA, Percival SL. The effect of pH on the extracellular matrix and biofilms. Advance in Wound Care. 2015;4(7):431\u20139.","journal-title":"Advance in Wound Care"},{"issue":"5","key":"921_CR191","doi-asserted-by":"publisher","first-page":"e01667","DOI":"10.1128\/mBio.01667-14","volume":"5","author":"L Foulston","year":"2014","unstructured":"Foulston L, et al. The extracellular matrix of Staphylococcus aureus biofilms comprises cytoplasmic proteins that associate with the cell surface in response to decreasing pH. MBio. 2014;5(5):e01667-e1714.","journal-title":"MBio"},{"issue":"2","key":"921_CR192","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/wrr.12125","volume":"22","author":"SL Percival","year":"2014","unstructured":"Percival SL, et al. The effects of pH on wound healing, biofilms, and antimicrobial efficacy. Wound Repair Regen. 2014;22(2):174\u201386.","journal-title":"Wound Repair Regen"},{"issue":"1","key":"921_CR193","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1128\/jb.95.1.152-156.1968","volume":"95","author":"W Garrard","year":"1968","unstructured":"Garrard W, Lascelles J. Regulation of Staphylococcus aureus lactate dehydrogenase. J Bacteriol. 1968;95(1):152\u20136.","journal-title":"J Bacteriol"},{"issue":"3","key":"921_CR194","doi-asserted-by":"publisher","first-page":"e58277","DOI":"10.1371\/journal.pone.0058277","volume":"8","author":"MT Ferreira","year":"2013","unstructured":"Ferreira MT, et al. Effect of oxygen on glucose metabolism: utilization of lactate in Staphylococcus aureus as revealed by in vivo NMR studies. PLoS One. 2013;8(3):e58277\u2013e58277.","journal-title":"PLoS One"},{"key":"921_CR195","doi-asserted-by":"crossref","unstructured":"Torres IM, et al.\u00a0Acidosis increases the susceptibility of respiratory epithelial cells to Pseudomonas aeruginosa-induced cytotoxicity. Am J Physiol Lung Cell Mol Physiol. 2017;313(1): p. L126-L137.","DOI":"10.1152\/ajplung.00524.2016"},{"issue":"6","key":"921_CR196","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/bjs.1800780607","volume":"78","author":"C Welbourn","year":"1991","unstructured":"Welbourn C, et al. Pathophysiology of ischaemia reperfusion injury: central role of the neutrophil. Br J Surg. 1991;78(6):651\u20135.","journal-title":"Br J Surg"},{"issue":"6","key":"921_CR197","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/BF01715494","volume":"22","author":"HP Simmen","year":"1994","unstructured":"Simmen HP, et al. Analysis of pH, pO2 and pCO2 in drainage fluid allows for rapid detection of infectious complications during the follow-up period after abdominal surgery. Infection. 1994;22(6):386\u20139.","journal-title":"Infection"},{"issue":"3","key":"921_CR198","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s11095-012-0927-x","volume":"30","author":"NJ Irwin","year":"2013","unstructured":"Irwin NJ, et al. Infection-responsive drug delivery from urinary biomaterials controlled by a novel kinetic and thermodynamic approach. Pharm Res. 2013;30(3):857\u201365.","journal-title":"Pharm Res"},{"issue":"8","key":"921_CR199","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1021\/acs.molpharmaceut.6b00402","volume":"13","author":"CP McCoy","year":"2016","unstructured":"McCoy CP, et al. An infection-responsive approach to reduce bacterial adhesion in urinary biomaterials. Mol Pharm. 2016;13(8):2817\u201322.","journal-title":"Mol Pharm"},{"issue":"5","key":"921_CR200","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1021\/nn3008383","volume":"6","author":"AF Radovic-Moreno","year":"2012","unstructured":"Radovic-Moreno AF, et al. Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics. ACS Nano. 2012;6(5):4279\u201387.","journal-title":"ACS Nano"},{"key":"921_CR201","doi-asserted-by":"crossref","unstructured":"Albayaty Y, et al.\u00a0pH-Responsive copolymer micelles to enhance itraconazole efficacy against Candida albicans biofilms. J Mater Chemi B. 2020;8.","DOI":"10.1039\/C9TB02586C"},{"issue":"17","key":"921_CR202","doi-asserted-by":"publisher","first-page":"4217","DOI":"10.1021\/acs.langmuir.6b00338","volume":"32","author":"L Boge","year":"2016","unstructured":"Boge L, et al. Lipid-based liquid crystals as carriers for antimicrobial peptides: phase behavior and antimicrobial effect. Langmuir. 2016;32(17):4217\u201328.","journal-title":"Langmuir"},{"key":"921_CR203","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3389\/fmicb.2018.00915","volume":"9","author":"J Zhang","year":"2018","unstructured":"Zhang J, et al. Amikacin liposome inhalation suspension (ALIS) penetrates non-tuberculous mycobacterial biofilms and enhances amikacin uptake into macrophages. Front Microbiol. 2018;9:915\u2013915.","journal-title":"Front Microbiol"},{"key":"921_CR204","doi-asserted-by":"publisher","first-page":"6949","DOI":"10.2147\/IJN.S141709","volume":"12","author":"M Alhariri","year":"2017","unstructured":"Alhariri M, et al. Efficacy of neutral and negatively charged liposome-loaded gentamicin on planktonic bacteria and biofilm communities. Int J Nanomed. 2017;12:6949\u201361.","journal-title":"Int J Nanomed"},{"issue":"1","key":"921_CR205","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/pharmaceutics8010006","volume":"8","author":"D Cipolla","year":"2016","unstructured":"Cipolla D, Blanchard J, Gonda I. Development of liposomal ciprofloxacin to treat lung infections. Pharmaceutics. 2016;8(1):6.","journal-title":"Pharmaceutics"},{"key":"921_CR206","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1136\/thoraxjnl-2013-203207","volume":"68","author":"D Serisier","year":"2013","unstructured":"Serisier D, et al. Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial. Thorax. 2013;68:812\u20137.","journal-title":"Thorax"},{"issue":"3","key":"921_CR207","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S2213-2600(18)30427-2","volume":"7","author":"CS Haworth","year":"2019","unstructured":"Haworth CS, et al. Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials. Lancet Respir Med. 2019;7(3):213\u201326.","journal-title":"Lancet Respir Med"},{"issue":"10","key":"921_CR208","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1016\/j.clinthera.2019.08.010","volume":"41","author":"S Sarkar","year":"2019","unstructured":"Sarkar S, Heise MT. Mouse models as resources for studying infectious diseases. Clin Ther. 2019;41(10):1912\u201322.","journal-title":"Clin Ther"},{"key":"921_CR209","doi-asserted-by":"publisher","first-page":"5258727","DOI":"10.1155\/2016\/5258727","volume":"2016","author":"GM Lavelle","year":"2016","unstructured":"Lavelle GM, et al. Animal models of cystic fibrosis pathology: phenotypic parallels and divergences. Biomed Res Int. 2016;2016:5258727.","journal-title":"Biomed Res Int"},{"key":"921_CR210","doi-asserted-by":"crossref","unstructured":"Artzy-Schnirman A, Lehr CM, Sznitman J.\u00a0Advancing human in vitro pulmonary disease models in preclinical research: opportunities for lung-on-chips. Expert Opin Drug Deliv. 2020;p. 1\u20135.","DOI":"10.1080\/17425247.2020.1738380"},{"key":"921_CR211","doi-asserted-by":"crossref","unstructured":"Scriboni AB, et al.\u00a0Fusogenic Liposomes Increase the Antimicrobial Activity of Vancomycin Against Staphylococcus aureus Biofilm. Front Pharmacol. 2019;10(1401).","DOI":"10.3389\/fphar.2019.01401"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-021-00921-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-021-00921-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-021-00921-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T08:43:26Z","timestamp":1724575406000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-021-00921-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,5]]},"references-count":211,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["921"],"URL":"https:\/\/doi.org\/10.1007\/s13346-021-00921-w","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,5]]},"assertion":[{"value":"20 January 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethics approval was required for this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"No animal or human studies were carried out by the authors for this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or Animals"}},{"value":"The other authors declare no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}